Pernix Therapeutics Holdings, Inc. (PTX)

Pernix Therapeutics Holdings, Inc. (PTX)

$0.21 USD

0.01 (-4.55%)

Updated Mar 4 8:00pm

Add PTX to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 207 in Medical - Pharmaceuticals

See all “A” rated Strong Buy stocks

PTX Daily Price Range
PTX 52-Week Price Range

PTX News Stream

Event/Time News Detail Start End Change
Loading, please wait...
View All PTX News

Pernix Therapeutics Holdings, Inc. (PTX) Company Bio

Pernix Therapeutics Holdings, Inc. develops, manufactures, markets, and sells branded and generic pharmaceutical products. The company’s product include CEDAX, an oral cephalosporin used for the treatment of mild to moderate acute bacterial exacerbations of chronic bronchitis, middle ear infection due to haemophilus influenza, or streptococcus pyogene; Zutripro, Rezira, and Vituz for the relief of cough and nasal congestion; and OMECLAMOX-PAK a gastroenterology product. The company was founded in 1996 and is based in Morristown, New Jersey.

PTX Stock Chart More Charts

PTX Price/Volume Stats

Current price $0.21
Prev. close $0.22
Day low $0.20
Day high $0.24
50-day MA $0.52
200-day MA $1.23
52-week high $3.30
52-week low $0.20
Volume 1,010,500
Avg. volume 2,010,779
Dividend yield N/A
Market Cap 3.05M

PTX Social Stream

Loading social stream, please wait...

View Full PTX Social Stream

PTX Returns

1-mo N/A
3-mo N/A
6-mo -52.27%
1-year -91.32%
3-year -57.14%
5-year -97.57%
YTD -50.00%
2018 -82.50%
2017 23.71%
2016 -34.24%
2015 -68.58%
2014 272.62%
Page generated in 0.6388 seconds.